Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000118571 | SCV000152977 | benign | not specified | 2015-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000463563 | SCV000562714 | benign | Intellectual disability, autosomal dominant 5 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000463563 | SCV000743890 | benign | Intellectual disability, autosomal dominant 5 | 2014-10-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313923 | SCV000847748 | benign | Inborn genetic diseases | 2016-05-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000857539 | SCV001145599 | benign | not provided | 2019-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000857539 | SCV001871893 | benign | not provided | 2019-08-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000857539 | SCV002586111 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SYNGAP1: BP4, BP7, BS1, BS2 |
Fulgent Genetics, |
RCV000463563 | SCV002799965 | likely benign | Intellectual disability, autosomal dominant 5 | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000463563 | SCV000734495 | likely benign | Intellectual disability, autosomal dominant 5 | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004549588 | SCV004731652 | benign | SYNGAP1-related disorder | 2019-10-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |